Sage Therapeutics has agreed to be acquired by Supernus Pharma in a deal valued at around $571 million, bringing together two companies working on central nervous system therapies that have suffered ...
The government moves to make it easier to drill, mine and graze on 50 million acres of land in the West. By Lisa Friedman The Trump administration weakened protections on Monday for the vulnerable ...
Add Yahoo as a preferred source to see more of our stories on Google. A local contestant who reached the end of the 49th season of Survivor and finished in third place says the experience left her ...
Make sure not to miss this valuable item your first time around. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Add us as a preferred source on ...
Office owner Sage’s centennial celebration has come and gone, and while CEO and President Jonathan Iger might not know where he wants Sage to be in another 100 years, he certainly knows where he wants ...
BigBear.ai has agreed to acquire Ask Sage, a generative artificial intelligence platform designed for secure deployment of AI models and agentic systems across defense, national security and other ...
Transform into Naruto Sage Mode with this detailed cosplay tutorial. The Dodgers' historic World Series Game 3 victory, by the numbers Trump’s Message to Bondi Sparks DOJ Firestorm Florida property ...
Ask Sage has launched Ask Sage Edge, a turnkey field-deployable AI solution developed with Hewlett Packard Enterprise, NVIDIA, Meta, and Nutanix. The platform brings production-grade Generative AI ...
ROCKVILLE, Md., July 31, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN) (“Supernus”) today announced that it has successfully completed its previously announced acquisition of ...
Cindy Taff is CEO and co-founder of Sage Geosystems. The company was founded in 2020 and is developing energy storage and geothermal baseload technologies deep in the earth and above temperatures of ...
Sage Therapeutics SAGE announced that Supernus Pharmaceuticals SUPN has agreed to acquire SAGE through a tender offer of $8.50 per share in cash, totaling around $561 million. Additionally, ...